摘要
为了探讨瑞巴派特治疗十二指肠溃疡的疗效,将102例十二指肠溃疡患者随机分为A、B、C 3组,A组给予瑞巴派特+奥美拉唑+阿莫西林+克拉霉素;B组给予铝碳酸镁+奥美拉唑+阿莫西林+克拉霉素;C组给予硫糖铝+奥美拉唑+阿莫西林+克拉霉素。结果显示在总S期和S2期获得率及溃疡直径减小程度等方面A组明显高于B、C两组。瑞巴派特是促进溃疡愈合疗效较高的药物。
To study the effect of rebamipide on the patients with duodenal ulcer,one hundred and two patients with duodenal ulcer were divided randomly into group A,B and C;group A： rebamipide ＋ omeprazole ＋ amoxicillin ＋ clarithromycin;group B： hydrotalcite ＋ omeprazole ＋ amoxicillin ＋clarithromycin;group C： sucralfate ＋ omeprazole ＋ amoxicillin ＋ clarithromycin.The pick-up rates of phase S and S2 and the reduce degree of duodenal ulcer diameter in group A were obviously higher than those in group B and C.Rebamipide is the valuable drug in the clinical treatment of duodenal ulcer.
出处
《胃肠病学和肝病学杂志》
CAS
2010年第1期35-35,39,共2页
Chinese Journal of Gastroenterology and Hepatology
